高密度脂蛋白胆固醇是否可以预防心血管疾病?
Alexander C Razavi1, Vardhmaan Jain1, Gowtham R Grandhi2
1Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.
The Journal of clinical endocrinology and metabolism
|July 12, 2023
概括
高密度脂蛋白胆固醇 (HDL-C) 可能不是对动脉样硬化心血管疾病 (ASCVD) 的普遍保护因素. 矛盾的是,非常高的HDL-C水平与增加的死亡率有关,这表明在ASCVD风险中扮演着复杂的角色.
科学领域:
- 心血管医学 心血管医学
- 脂质代谢 脂质代谢是什么
- 动脉样硬化研究 动脉样硬化研究
背景情况:
- 高密度脂蛋白 (HDL) 和高密度脂蛋白胆固醇 (HDL-C) 传统上与逆胆固醇运输和降低动脉样硬化心血管疾病 (ASCVD) 风险有关.
- 旨在增加HDL-C的治疗干预措施未能在接受他类药物治疗的患者中减少ASCVD事件.
- 门德尔随机化研究质疑HDL-C在ASCVD风险中的直接因果作用.
研究的目的:
- 重新评估HDL-C对ASCVD风险评估的贡献.
- 检查HDL-C水平和ASCVD之间的复杂关系.
- 讨论HDL-C在ASCVD风险评估,治疗和预防中的未来作用.
主要方法:
- 对HDL-C的生物功能和规范值的审查.
- 对HDL-C和ASCVD风险的流行病学研究的分析.
- 检查最近关于非常高的HDL-C水平和死亡率的证据.
主要成果:
- 传统的HDL-C作为一种保护因素的观点受到最近发现的挑战.
- 在HDL-C和亚临床动脉样硬化之间存在非线性U形关系.
- 非常高的HDL-C水平 (男性≥80 mg/dL,女性≥100 mg/dL) 矛盾地与所有原因和ASCVD死亡率的增加有关.
结论:
- HDL-C并不是一种普遍的预防动脉样硬化的保护因素.
- 在ASCVD风险评估中HDL-C的作用需要重新定义.
- 需要进一步的研究来澄清HDL-C在动脉样硬化和临床ASCVD中的确切作用.
相关概念视频
Coronary Artery Disease IV: Preventive Measures
25
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
25
Cholesterol: Significance and Regulation
592
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
592
Blood Studies for Cardiovascular System III: Serum Lipid Profile
201
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
201
Lipids: Dietary Sources and Requirements
851
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
851
Coronary Artery Disease I: Introduction
25
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
25
Atherosclerosis III: Management
13
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
13


